From trial to practice: The Princess Margaret Hospital (PMH) experience with docetaxel and prednisone for men with metastatic castration resistant prostate cancer (mCRPC).
Arnoud Templeton
No relevant relationships to disclose
Lisa Wang
No relevant relationships to disclose
Francisco Vera-Badillo
No relevant relationships to disclose
Mirna Attalla
No relevant relationships to disclose
Paulo De Gouveia
No relevant relationships to disclose
Raya Leibowitz-Amit
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Malcolm J. Moore
No relevant relationships to disclose
Srikala S. Sridhar
No relevant relationships to disclose
Anthony Michael Joshua
No relevant relationships to disclose
Ian Tannock
Consultant or Advisory Role - Sanofi (U); Sanofi (U)
Research Funding - Sanofi ; Sanofi ; Sanofi